Alimera Sciences (ALIM) Revenue & Revenue Breakdown
Alimera Sciences Revenue Highlights
Latest Revenue (Y)
$80.75M
Latest Revenue (Q)
$23.01M
Main Segment (Y)
United States Segment
Alimera Sciences Revenue by Period
Alimera Sciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $80.75M | 49.19% |
| 2022-12-31 | $54.13M | -8.30% |
| 2021-12-31 | $59.03M | 16.15% |
| 2020-12-31 | $50.82M | -5.79% |
| 2019-12-31 | $53.94M | 14.85% |
| 2018-12-31 | $46.97M | 30.79% |
| 2017-12-31 | $35.91M | 4.60% |
| 2016-12-31 | $34.33M | 53.01% |
| 2015-12-31 | $22.44M | 166.39% |
| 2014-12-31 | $8.42M | 349.95% |
| 2013-12-31 | $1.87M | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2007-12-31 | - | 100.00% |
| 2006-12-31 | - | - |
Alimera Sciences generated $80.75M in revenue during NA 2023, up 49.19% compared to the previous quarter, and up 171.93% compared to the same period a year ago.
Alimera Sciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $23.01M | -12.53% |
| 2023-12-31 | $26.31M | 12.59% |
| 2023-09-30 | $23.36M | 33.22% |
| 2023-06-30 | $17.54M | 29.47% |
| 2023-03-31 | $13.55M | -3.44% |
| 2022-12-31 | $14.03M | 3.17% |
| 2022-09-30 | $13.60M | -6.89% |
| 2022-06-30 | $14.60M | 22.74% |
| 2022-03-31 | $11.90M | -14.76% |
| 2021-12-31 | $13.96M | 14.86% |
| 2021-09-30 | $12.15M | -44.00% |
| 2021-06-30 | $21.70M | 93.53% |
| 2021-03-31 | $11.21M | -18.59% |
| 2020-12-31 | $13.77M | 10.43% |
| 2020-09-30 | $12.47M | 24.26% |
| 2020-06-30 | $10.04M | -30.94% |
| 2020-03-31 | $14.54M | -16.22% |
| 2019-12-31 | $17.35M | 35.00% |
| 2019-09-30 | $12.85M | 18.38% |
| 2019-06-30 | $10.86M | -15.79% |
| 2019-03-31 | $12.89M | -14.71% |
| 2018-12-31 | $15.11M | 35.71% |
| 2018-09-30 | $11.14M | 2.02% |
| 2018-06-30 | $10.92M | 11.38% |
| 2018-03-31 | $9.80M | 7.22% |
| 2017-12-31 | $9.14M | -6.56% |
| 2017-09-30 | $9.78M | -5.63% |
| 2017-06-30 | $10.37M | 56.66% |
| 2017-03-31 | $6.62M | -38.02% |
| 2016-12-31 | $10.68M | 28.67% |
| 2016-09-30 | $8.30M | -13.17% |
| 2016-06-30 | $9.56M | 64.75% |
| 2016-03-31 | $5.80M | -0.38% |
| 2015-12-31 | $5.82M | -15.62% |
| 2015-09-30 | $6.90M | 19.48% |
| 2015-06-30 | $5.78M | 46.67% |
| 2015-03-31 | $3.94M | 126.19% |
| 2014-12-31 | $1.74M | -27.70% |
| 2014-09-30 | $2.41M | 9.95% |
| 2014-06-30 | $2.19M | 5.09% |
| 2014-03-31 | $2.08M | 122.89% |
| 2013-12-31 | $935.00K | 23.35% |
| 2013-09-30 | $758.00K | 323.46% |
| 2013-06-30 | $179.00K | 100.00% |
| 2013-03-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2012-09-30 | - | 100.00% |
| 2012-06-30 | - | 100.00% |
| 2012-03-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2011-09-30 | - | 100.00% |
| 2011-06-30 | - | 100.00% |
| 2011-03-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2010-09-30 | - | 100.00% |
| 2010-06-30 | - | 100.00% |
| 2010-03-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2009-09-30 | - | 100.00% |
| 2009-06-30 | - | 100.00% |
| 2009-03-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2008-09-30 | - | 100.00% |
| 2008-06-30 | - | 100.00% |
| 2008-03-31 | - | 100.00% |
| 2007-06-30 | - | - |
Alimera Sciences generated $23.01M in revenue during Q1 2024, up -12.53% compared to the previous quarter, and up 164.02% compared to the same period a year ago.
Alimera Sciences Revenue Breakdown
Alimera Sciences Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| International Segment | $24.04M | $19.93M | $32.29M | $26.01M | $21.66M |
| United States Segment | $56.71M | $34.20M | $26.74M | $24.81M | $32.28M |
| Other Segments | - | - | - | - | - |
Alimera Sciences's latest annual revenue breakdown by segment (product or service), as of Dec 23: United States Segment (70.23%), and International Segment (29.77%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| International Segment | $8.46M | $7.12M | $5.30M | $5.66M | $5.96M | $4.61M | $4.68M | $5.66M | $4.98M | $5.57M | $5.24M | $15.92M | $5.57M | $6.41M | $5.51M | $6.62M | $7.47M | $7.84M | $4.16M | $3.54M |
| United States Segment | $14.55M | $19.19M | $18.06M | $11.88M | $7.58M | $9.42M | $8.92M | $8.94M | $6.92M | $8.39M | $6.92M | $5.79M | $5.65M | $7.36M | $6.96M | $3.42M | $7.07M | $9.51M | $8.69M | $7.32M |
| Other Segments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alimera Sciences's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: United States Segment (63.24%), and International Segment (36.76%).
Alimera Sciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PTPI | Petros Pharmaceuticals | $5.82B | $1.39M |
| ORGO | Organogenesis | $433.14M | $130.23M |
| LFCR | Lifecore Biomedical | $128.26M | $24.70M |
| ALIM | Alimera Sciences | $80.75M | $23.01M |
| DERM | Journey Medical | $79.18M | $14.86M |
| ADMP | Adamis Pharmaceuticals | $4.76M | $9.06M |
| SXTC | China SXT Pharmaceuticals | $1.97M | $939.58K |
| CYTH | Cyclo Therapeutics | $1.08M | $123.10K |
| LSDI | Lucy Scientific Discovery | $7.05K | $9.68K |
| SHPH | Shuttle Pharmaceuticals | - | - |
ALIM Revenue FAQ
What is Alimera Sciences’s yearly revenue?
Alimera Sciences's yearly revenue for 2023 was $80.75M, representing an increase of 49.19% compared to 2022. The company's yearly revenue for 2022 was $54.13M, representing a decrease of -8.30% compared to 2021. ALIM's yearly revenue for 2021 was $59.03M, representing an increase of 16.15% compared to 2020.
What is Alimera Sciences’s quarterly revenue?
Alimera Sciences's quarterly revenue for Q1 2024 was $23.01M, a -12.53% decrease from the previous quarter (Q4 2023), and a 69.87% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $26.31M, a 12.59% increase from the previous quarter (Q3 2023), and a 87.51% increase year-over-year (Q4 2022). ALIM's quarterly revenue for Q3 2023 was $23.36M, a 33.22% increase from the previous quarter (Q2 2023), and a 71.82% increase year-over-year (Q3 2022).
What is Alimera Sciences’s revenue growth rate?
Alimera Sciences's revenue growth rate for the last 3 years (2021-2023) was 36.80%, and for the last 5 years (2019-2023) was 49.70%.
What are Alimera Sciences’s revenue streams?
Alimera Sciences's revenue streams in c 23 are International Segment, and United States Segment. International Segment generated $24.04M in revenue, accounting 29.77% of the company's total revenue, up 20.66% year-over-year. United States Segment generated $56.71M in revenue, accounting 70.23% of the company's total revenue, up 65.81% year-over-year.
What is Alimera Sciences’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Alimera Sciences was United States Segment. This segment made a revenue of $56.71M, representing 70.23% of the company's total revenue.